Abbott Acquires Kalila Medical and Expands Abalation Catheter Offerings
| Printer friendly version
On February 2nd, 2016, Abbott announced its acquisition of Kalila Medical, Inc., a private medical device company using cardiac electrophysiology procedures for the treatment of heart rhythm disorders. According to the press release, the California-based company developed a steerable sheath (Vado®) for atrial fibrillation and other electrophysiology procedures. The technology helps clinicians by improving torque response, prevent whipping, and provide better navigation ability.
“Atrial fibrillation is a serious condition that increases the risk of stroke and causes severe symptoms in many patients, but remains undertreated today because current technologies have limited effectiveness,” said electrophysiology GM Michael Pederson. “With this acquisition, Abbott gains a unique technology to expand our portfolio of tools for the treatment of atrial fibrillation and other heart rhythm disorders. We look forward to initiating the launch of this innovative sheath in the United States and Europe in the coming weeks.”
Abbott has made other acquisitions relating to arrhythmia diagnosis and management. In October, 29, 2014, Abbott announced its agreement to purchase Topera, Inc. for $250 million, another private medical device company that developed a novel diagnostic catheter and mapping software, which help physicians identify the electrical source of complex cardiac arrhythmias. Abbott also secured the right to purchase Advance Cardiac Therapeutics, Inc. in the future, a medical device company that develops temperature-sensing irrigated radiofrequency ablation catheters for treatment of atrial fibrillation. Abbott also joined with GE for a collaborative effort to improve diagnostics for patients with atrial fibrillation.
According to the press release, atrial fibrillation is the most common heart rhythm disorder, with five million new cases reported annually. Some estimate the global electrophysiology market to grow at a compound annual growth rate of 10.3% from 2014 to 2019, to reach a market of $4.73 billion.
Related
Keith Lim
Keith Lim is an associate in the firm's Orange County office. Mr. Lim practices intellectual property law, with a focus on patents.
He worked at Lockheed Martens Corporation as an inventor, where he graduated from their leadership program, completed his Master’s degree, obtained a patent award, and became the youngest member of the Patent Review Board. His experiences involved FPGA firmware coding, system architecture for transceivers, RF path analysis, Matlab simulation coding for sonar systems and a space fence, and hands-on integration and test. He also worked for BAE Systems, Bell-Labs, and Micron Technology.
Before attending law school, Mr. Lim worked for a law firm in Korea in their international department. During law school, he served as a notes editor in the Michigan Telecommunications and Technology Law Review.
Mr. Lim joined the firm in 2015.
Click here to read full bio View all posts published by Keith Lim »
By using this blog, you agree and understand that no information is being provided in the context of any attorney-client relationship. You further agree and understand that nothing herein is intended to be legal advice. This blog is solely informational in nature, and is not intended as, and should not be used as, a substitute for competent legal advice from a retained and licensed attorney in your state. Knobbe Martens LLP makes no representations or warranties as to the accuracy, completeness, timeliness or availability of the information in this blog. Knobbe Martens LLP will not be liable for any injury or damages relating to your use of, or access to, any such information. Knobbe Martens LLP undertakes no obligation to correct or update information on this blog, which may be incorrect or become incorrect or out of date over time. Knobbe Martens LLP reserves the right to alter or delete content or information on the blog at any time. This blog contains links and references to other websites and publications that you may find of interest. Knobbe Martens LLP does not control, promote, endorse or otherwise have any affiliation with any other websites or publications unless those websites or publications expressly state such an affiliation. Knobbe Martens LLP further has no responsibility for, and makes no representations regarding, the content, accuracy or any other aspect of the information in such websites or publications.
Share